Back |
home / stock / dyai / dyai message board
Subject | By | Source | When |
---|---|---|---|
whytestocks: $DYAI News Article - Making Profits, Saving Lives with Gene Therapy | whytestocks | investorshangout | 03/12/2019 1:25:39 PM |
PoemStone: $DYAI Flag PRs | PoemStone | investorshangout | 12/31/2015 4:08:31 PM |
Emylers: DYAI Financials 07/16/2014 06:05:47 Dyadic International, Inc. Period Ending Dec 31, 2013 D | Emylers | investorshangout | 07/16/2014 11:05:44 AM |
Stock Tracker: Latest Dyadic International (DYAI) Headlines Dyadic International To Announce Year-En | Stock_Tracker | investorshangout | 03/09/2014 8:16:12 PM |
chartguy89: DYAI 1.72 Stock Charts $DYAI 1 Month Chart | chartguy89 | investorshangout | 03/07/2014 4:01:35 AM |
chartguy89: DYAI Stock Charts Last: -0.01 Tuesday, February 25, 2014 at 1:49:10 PM $DYAI 1 M | chartguy89 | investorshangout | 02/25/2014 6:49:22 PM |
News, Short Squeeze, Breakout and More Instantly...
Dyadic International Inc. Company Name:
DYAI Stock Symbol:
OTCMKTS Market:
Dyadic International Inc. Website:
JUPITER, Fla., June 28, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI), announced today that they have entered into a development and commercialization partnership with Proliant Health and Biologicals (PHB), a leading supplier of purified proteins for ...
JUPITER, Fla., May 30, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and animal vaccines and therapeutics, as well a...
Human Health Sector Final Clinical Study Report has been issued for the First-In-Human Phase 1 clinical trial demonstrating safety and antibody response for DYAI-100, a recombinant protein receptor binding domain booster vaccine candidate for protection against C...